Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Novelty in the treatment of episodic tension-type headache

https://doi.org/10.14412/2074-2711-2010-118

Full Text:

Abstract

Frequent episodic tension-type headache (ETTH) is a serious medical problem that is primarily due to its high prevalence. Nonsteroidal anti-inflammatory drugs (NSAIDs) whose efficiency is determined by the rapid and complete regression of cephalgia are primarily used to relieve an ETTH attack. One of the ways to enhance the effect of NSAIDs is their combination with agents that accelerate their absorption or potentiate their action, with caffeine in particular; however, the use of combination agents is limited by a risk for drug-induced headache. A step on the road to the design of effective and safe analgesics has been the development of the combination drug Novigan that contains ibuprofen (400 mg) and the spasmolytics pitofenone (5 mg) and fenpiverinium (0.1 mg).
Objective: to study the efficacy of Novigan versus ibuprofen 400 mg in relieving an ETTH attack.
Subjects and methods. Fifty patients (mean age 37.1±10.9 years) with frequent ETTH that met the criteria of the International Classification of Headache Disorders, 2nd Edition, were examined. For relief of ETTH attacks, 30 patients used Novigan and 20 took ibuprofen in a dose of 400 mg. Results. There was a significant reduction in the intensity of cephalgia 49.9±35.8 and 68.2±45.9 min after drug administration in the Novigan and ibuprofen 400 mg groups, respectively (p = 0.007). The proportion of respondents was higher in the Novigan group (73.3%) than that in the ibuprofen 400 mg group (60%), which is close to the statistically significant difference (p = 0.085). The efficacy predictors were less pain intensity (p < 0.001) and a shorter time after onset (p < 0.001) in the ibuprofen 400 mg group at administration of the drug
and only less pain intensity in the Novigan group at that moment (p = 0.07).
Conclusion. Novigan is a combination analgesic that rapidly and effectively relieves an ETTH attack, including that of high intensity, as well
as extended ETTH attack.

References

1. <div><p>Международная классификация головных болей. 2-е изд. 2003;380 с.</p><p>Фокина Н.М. Лечение эпизодической головной боли напряжения у молодых людей. Врач 2007(спец. вып.):55-6.</p><p>Стайнер Т.Д., Пемелера К., Йенсен Р. и др. Европейские принципы ведения пациентов с наиболее распространенными формами головной боли в общей практике. М.: ОГГИ. Рекламная продукция, 2010;56 с.</p><p>Осипова В.В. Головная боль напряжения. М.: ОГГИ. Рекламная продукция, 2009;44 с.</p><p>Осипова В.В. Головная боль напряжения: диагностика и терапия. Вестн семейн мед 2010;2:26-30.</p><p>Packman B., Packman E., Doyle G. et al. Solubilized ibuprofen: evaluation of onset, relief, and safety of a novel formulation in the treatment of episodic tension-type headache. Headache 2000;40:561-7.</p><p>Sparano N. Is the combination of ibuprofen and caffeine effective for the treatment of a tension- type headache? J Fam Pract 2001;50:10.</p><p>Diamond S., Balm T.K., Freitag F.G. Ibuprofen plus caffeine in the treatment of tension-type headache. Clin Pharmacol Ther 2000;68(3):312-9.</p><p>Bigal M.E., Lipton R.B. What predicts the change from episodic to chronic migraine? Curr Opin Neurol 2009;22:269-76.</p><p>Chaudhary A., Gupta R.L. Double blind, randomised, parallel, prospective, comparative, clinical evaluation of a combination of antispasmodic analgesic Diclofenac + Pitofenone + Fenpiverinium (Manyana vs Analgin + Pitofenone + Fenpiverinium (Baralgan) in biliary, ureteric and intestinal colic. J Indian Med Assoc 1999;97:244-5.</p><p>Golhar K.B., Gupta R.L. Open labelled evaluation of injection Manyana (a combination of diclofenac + pitofenone + fenpiverinium) in ureteric, biliary and intestinal spasm - a preliminary report. J Indian Med Assoc 1999;97:398-400.</p></div><br />


For citation:


Tabeeva G.R., Azimova Y.E., Tabeyeva G.R., Azimova Y.E. Novelty in the treatment of episodic tension-type headache. Neurology, Neuropsychiatry, Psychosomatics. 2010;2(4):57-62. (In Russ.) https://doi.org/10.14412/2074-2711-2010-118

Views: 374


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)